The FDA approved the first Ebola vaccine
The US Food and Drug Administration (FDA) for the first time approved the Ebola virus (EVD) vaccine for people 18 years of age and older.
Browse ScienceInfo articles and explainers related to Ebola Vaccine.
15 published items.
The US Food and Drug Administration (FDA) for the first time approved the Ebola virus (EVD) vaccine for people 18 years of age and older.
The European Pharmaceutical Commission has approved the circulation of the world's first Ervebo vaccine (rVSV -G-ZEBOV-GP) to prevent Ebola.
Although the initial results of this vaccine are very promising, changes related to new medical research regulations on primates can limit more intensive experiments.
Researchers have successfully developed the Ebola virus vaccine with efficacy of up to 100%.
It is expected that 300,000 doses of Ebola vaccine will be tested in May.
Swiss University hospital researchers (HUG) based in Switzerland on January 5 announced that they will continue testing an Ebola virus vaccine after a pause.
The clinical trial of an Ebola vaccine in Switzerland was suspended, after four patients complained of joint pain in their legs and arms.
A new Ebola vaccine has just been successfully developed in the United States. Human clinical trials show safe and positive results.
Doctors Without Borders (MSF) will clinically test two antiviral drugs and blood transfusions on hundreds of Ebola patients in Guinea and Liberia in December.
According to WHO experts, tens of thousands of people in West Africa will be able to test the Ebola vaccine early next year.
The journalist citing Nature's scientific journal, Italy, has initially researched and developed an Ebola virus vaccine.
A dose of ChAd3 vaccine can help the monkeys in the laboratory immune to Ebola virus for a short time and a repeat dose will have a longer-lasting effect.
Researchers with the British pharmaceutical company will officially begin testing the Ebola vaccine on human bodies next week.
Researchers at the US National Institutes of Health (NIH) are preparing to conduct a human clinical trial of a new prospective Ebola virus vaccine, nearly a month earlie…
Canada will donate a small amount of experimental Ebola vaccine that it invented to the World Health Organization for use in Africa.